Chronic conditions (tendonitis, joint issues): Typically requires 48 weeks of consistent use to see substantial improvements, with continued benefits over 12+ weeks
It promotes the repair of tendons, ligaments, muscles, and even nerves by increasing blood flow to injured areas
As we age, tendons lose elasticity, making bursae more prone to irritation
Loren Pickart first isolated and identified GHK-Cu in 1973, discovering that this peptide complex demonstrated wound healing properties far exceeding what either component achieved alone
If your B12 levels are already normal, injections are unlikely to make a meaningful difference
Tirzepatide targets GLP-1 and GIP receptors, while Retatrutide activates GLP-1, GIP, and glucagon receptors, making it a triple agonist peptide